The replication of human cytomegalovirus (CMV) and herpes simplex virus (HSV) was studied in three human embryo cell lines (CMV-Mj-HEL-1, CMVMj-HEL-2, and CMV-Mj-HEL-2,T-I) transformed in vitro by human CMV. Growth studies revealed that these cells were completely resistant to infection by CMV strains AD169 and Mj and partially resistant to HSV types I and 2. Neither virus DNA nor virus proteins were synthesized in the transformed cells infected with CMV ADt69. The HSV production in CMV-transformed human embryo lung (HEL) cells was delayed when compared to the virus production in normal HEL cells and spread of HSV c.p.e, was slower in the transformed cells. The treatment of normal HEL cells with a crude extract of CMV-transformed HEL cells also resulted in inhibition of the spread of c.p.e, of HSV types 1 and 2. The inhibitory effect was not due to interferon since vesicular stomatitis virus replication was not affected and several experiments showed that it was not due to mycoplasma. The presence of virus inhibitor molecules in CMV-transformed cells absent in normal HEL cells is postulated.
INTRODUCTION
The transformation of cells by viruses is usually followed by resistance to infection by the homologous virus (Rapp & Trulock, 197o) . In the case of cells transformed by herpes simplex virus (HSV) the resistance may be partial (Doller et al. I973) or complete (Darai & Munk, 1976) . The mechanism of resistance to superinfection is not clear but is probably due to a block in an early step in the replication cycle of the virus such as attachment, penetration or uncoating (Vogt & Ishizaki, 1966; Rapp & Trulock, I97O) . There is evidence that a soluble inhibitor (Doller, I977) extracted from transformed cells can be transferred to permissive cells making them resistant to the same virus. We previously reported (Geder et al. 1976 ) the malignant transformation of human embryo lung (HEL) cells by cytomegalovirus (CMV) strain Mj isolated from the prostate of a 3-year-old boy. Three transformed cell lines have been developed, all expressing CMV antigens in early passages. These cells appear completely resistant to superinfection with CMV and partially resistant to HSV. Furthermore, a substance which mediates this resistance can be extracted from transformed cells and transferred to normal HEL cells.
METHODS
Cell cultures and media. The history of three CMV-transformed cell lines (CMV-Mj-HEL-I, CMV-Mj-HEL-2, and CMV-Mj-HEL-E,T-I) has been published (Geder et aL I976) . At the time of the experiments reported here they had been passaged over I5o times in vitro and showed no detectable level of CMV-related antigens by immunofluorescence tests. HEL cells (Flow 5ooo) were obtained from Flow Laboratories (Rockville, Md., U.S.A.) and primary rabbit kidney (RK) ceils were cultured using standard procedures. Transformed cells were cultured in Ham medium with 20 ~o foetal bovine serum (FBS); HEL cells were cultured in Dulbecco's medium with Io % FBS; and RK cells were cultured in Eagle's medium with ~o % FBS. Sodium bicarbonate (o'o75 %), penicillin 0oo Units/ml), and streptomycin (Ioo #g [ml) were added to the culture media.
Virus strains and assay. The history and isolation of CMV-Mj has been reported (Rapp et al. I975) . A virus stock was prepared by infecting HEL cells in glass roller bottles with a virus to cell ratio (m.o.i.) of o.ox. The virus was harvested when about 75 % of the cells showed c.p.e, and most of the fuid was discarded since this isolate produces little extracellular virus. The cells were scraped from the glass and suspended in a small amount of medium. Infected cells were placed in a tube immersed in ice and sonicated for 6o s using a Lab-Sonic apparatus (Lab-Line Instruments, Inc., Melrose Park, Ill., U.S.A.). The suspension was mixed with an equal volume of 7o % sorbitol (MC [B Manufacturing Chemists, Norwood, Ohio, U.S.A.), dispensed in vials and frozen at -85 °C. CMV-Mj was in passage xo when used in this experiment. CMV ADI69 is routinely employed in this laboratory. CMV virus titres were determined by plaque count using the method of Wentworth & French 097o). Stocks of HSV-I (strain Patton) and HSV-z (strain 333) were also prepared in HEL cells and stored at -85 °C. HSV was assayed in RK monolayers by the plaque formation method (Doller et al. ~ 973) .
Virus growth studies. CMV-transformed cells and normal HEL cells were grown to confluency (about Io 8 cells/flasks) in 24 cm 2 flasks. CMV and HSV strains were inoculated at the m.o.i, indicated in the experiments reported. After 2 h adsorption, the unadsorbed virus was drawn off and 7 ml of fresh medium was added. Samples were taken at various time intervals and frozen. Virus was harvested by three cycles of freezing and thawing followed by sonication for x min.
Preparation of cell extracts. CMV-transformed cells were trypsinized and resuspended in phosphate-buffered saline (PBS). After three washings in PBS, the cell pellet was sonicated for I rain and cell debris was separated by centrifugation (900 g for I5 rain). The protein in the crude extract was measured using the method of Lowry et al. 095I) and a solution containing 5o #g protein/ml was prepared in Dulbecco's culture medium.
Assay of inhibitory activity in the cell extracts. Confluent monolayers of HEL cells in 6o mm Petri plates or 24 cm 2 flasks were used. The growth medium was discarded and replaced with Dulbecco's medium containing 5o #g protein [ml of extract. Unless otherwise indicated, a mixture of cell extract from the three cell lines, CMV-Mj-HEL-I, CMV-Mj-HEL-2, and CMV-Mj-HEL-z,T-I was used. Twenty-four hours later the medium was discarded and HSV (m.o.i. -o.ooi p.f.u./cell) was added to each plate. The virus was allowed to adsorb for 2 h at 37 °C, and 5 ml of Dulbecco's medium containing the CMVtransformed cell extract (50 #g protein/ml) was added. Plates were incubated in a humidified CO2 incubator at 37 °C for 72 h before harvesting and the virus harvested by three cycles of freeze-thawing followed by sonication for 6o s. It was then assayed for infectivity.
DNA labelling and analysis. CMV-transformed human cells (CMV-Mj-HEL-I and CMV-
On: Thu, 13 Dec 2018 04:37:59 Mj-HEL-2,T-I) were infected with CMV ADI69 at a m.o.i, of 5. Forty-eight hours postinfection (p.i.), 8H-thymidine (IO/zCi/ml) in Eagle's growth medium was added to the flasks. The label was allowed to absorb for an additional 24 h before harvest. At this time virus DNA synthesis was at its peak in permissive cells (St Jeor & Rapp, I973) . The DNA was then extracted with pronase (IO #g/ml), sarcosyl (io%), and EDTA (0.2 M; pH 8"0) mixed in the proportion of 2 : I : I respectively. The lysing mixture was allowed to act overnight at 37 °C, then 5o #1 of the lysate were placed on top of a neutral CsC1 gradient (initial density t'716 g/ml) and centrifuged in a Beckman preparative ultracentrifuge with a 4o'3 rotor, at ~ooooo g ,for 6o h. The gradients were collected by bottom puncture of the tubes, on to Whatman no. 3 paper discs. DNA was precipitated using 20 % trichloroacetic (TCA) acid and the radioactivity was determined in a liquid scintillation counter. 14C-labelled Klebsiella pneumoniae DNA, obtained from Dr S. St Jeor, was included in some gradients as a marker to identify the CMV DNA peak since this marker sediments at "717 g/ml (Andersson & Lindahl, ~976) .
Superinfection of CMV-transformed cells

Immunofluorescence (IF) tests.
The techniques used were the same as previously reported (Geder et al. ~ 976) .
RESULTS
CMV ADI69 failed to replicate in the CMV-transformed human cells. To determine whether an abortive infection occurred in the transformed human cells, coverslip cultures of CMV-Mj-HEL-I cells were infected with ADI69. Forty-eight hours later, the cells were stained by the indirect IF method. As a control, CMV-infected HEL cells were also tested. No CMV antigens were detected in the CMV-Mj-HEL-I cells at passage 250, either before or after infection with ADI69; although CMV antigens were routinely detected in the virus-infected non-transformed human cells.
Virus D N A was not synthesized after infection of the CMV-transformed cells by ADI69. * The concentration of the extract was adjusted to 50 #g protein/ml of medium. I HSV-2 produced (p.f.u./ml) in HEL cells in the absence of the extract at 72 h was taken as loo (3'I x io 7 p.f.u./ml).
of cell DNA synthesis in the transformed cells infected with ADI69 because the cell DNA peak was always higher (about four times the ct/rain) in the infected compared to the noninfected cell lysate.
The replication of HSV-I and HSV-2 was delayed in the CMV-transformed cells. (Table I) . At 24 h the virus titres obtained after infection of the transformed cells with HSV-] or HSV-2 were I to 3 logs lower than in HEL cells. The most significant effect was observed in tumour cell line CMV-Mj-HEL-2,T-r. The delay in HSV replication could be transferred to permissive HEL cells by a crude extract from CMVtransformed cells. The spread of c.p.e, was inhibited in the first 48 h p.i. (Fig. 4) when the cells were pre-treated with the extract. HEL cells pre-treated with an extract from transformed cells (50/zg protein/ml) also produced ~ to 2 log lower titres of virus than cells exposed to an extract from non-transformed HEL cells (Table z) .
The inhibitory activity of the extract from CMV-transformed cells was dose dependent (Fig. 5) ; 50 % inhibition of HSV-2 production was obtained with a concentration of protein as low as I2/zg/ml. The activity was dialysable and resistant to heating at 56 °C for 30 min (Table 3 )-The extract could be frozen at -85 °C or kept at 4 °C without loss of activity. The inhibitory substance did not sediment after centrifugation (1ooo0o g for 2 h) and u.v. irradiation (44 ergs/mm 2 [s for lo rain) diminished the activity from 90 to 75 % inhibition (Table 3) -
The inhibition was not due to interferon since vesicular stomatitis virus (VSV), a virus sensitive to interferon, was not inhibited in cells pre-treated with the extract at concentrations that inhibited HSV (our unpublished observations). However, the inhibition was not transferred to RK cells indicating that the inhibitory substance in the extract was at least partially species-specific. Direct treatment of HSV with the extract did not result in virus inactivation.
DISCUSSION
The resistance to superinfection with CMV exhibited by CMV-transformed human cells is another indication of the presence of the CMV genome in these cells. Approximately o'4 genome equivalents per cell (our unpublished results) are present in these lines, although CMV antigens were not detectable in later passages of CMV-Mj-HEL-I and CMV-Mj-HEL-2 cells (Geder et al. 1978) .
Transformation is not always followed by a complete resistance to superinfection with the homologous virus. Simian virus 4o (SV4o)-transformed lines are usually resistant (Sambrook, i972) but permissive clones of transformed cells can be isolated. HSV-2-transformed cells can be partially resistant (Doller et aL I973) or completely resistant (Darai & Munk, 1976) to HSV infection.
The mechanism of resistance to superinfection is not clear. In SV4o an early step in the replication cycle is blocked (Gluzman et aL I977) . In CMV-transformed human cells an early step prior to virus DNA replication is inhibited. The virus probably penetrates and uncoats in the transformed cells since cell DNA synthesis is stimulated. There is evidence An unexpected observation was a partial inhibition of HSV replication in the CMVtransformed cells, expressed as a delay in the HSV replication cycle. It could be that the same repressor molecule that completely inhibited an early step or enzyme in CMV replication caused a partial inhibition of the same enzyme in the related HSV.
The possibility of studying this inhibition at the molecular level is provided by the transfer of the inhibitory factor from CMV-transformed cells to normal HEL cells by means of a cell extract. The presence of an inhibitor in HSV-2-transformed hamster cells has been reported (Doller, 1977) . However, the characteristics of the inhibitory substance reported in this paper are somewhat different. It does not sediment when centrifuged at IOOOOO g for 2 h, is resistant to heating at 56 °C for 3o min, and demonstrates some sensitivity to u.v. irradiation. It is apparently active only in human cells, but is not identical to interferon since it does not inhibit VSV replication. More work is needed to fully characterize and identify this inhibitor and to clarify its mode of action.
